The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial (Q37374964)
Jump to navigation
Jump to search
scientific article published on 15 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial |
scientific article published on 15 December 2008 |
Statements
1 reference
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial (English)
1 reference
M Schiff
1 reference
C Pritchard
1 reference
J E Huffstutter
1 reference
V Rodriguez-Valverde
1 reference
P Durez
1 reference
X Zhou
1 reference
T Li
1 reference
K Bahrt
1 reference
S Kelly
1 reference
M Le Bars
1 reference
M C Genovese
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference